Daniel G. Calame

1.9k total citations
29 papers, 397 citations indexed

About

Daniel G. Calame is a scholar working on Molecular Biology, Genetics and Clinical Biochemistry. According to data from OpenAlex, Daniel G. Calame has authored 29 papers receiving a total of 397 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 9 papers in Genetics and 5 papers in Clinical Biochemistry. Recurrent topics in Daniel G. Calame's work include Metabolism and Genetic Disorders (5 papers), RNA modifications and cancer (5 papers) and Genomics and Rare Diseases (4 papers). Daniel G. Calame is often cited by papers focused on Metabolism and Genetic Disorders (5 papers), RNA modifications and cancer (5 papers) and Genomics and Rare Diseases (4 papers). Daniel G. Calame collaborates with scholars based in United States, Kuwait and Egypt. Daniel G. Calame's co-authors include Rick A. Wetsel, Dachun Wang, John E. Morales, Joseph L. Alcorn, Stacey L. Mueller‐Ortiz, Isabella Herman, R. Ford, Quan Lin, Esther Lau and Hesham M. Amin and has published in prestigious journals such as Nucleic Acids Research, Blood and The Journal of Immunology.

In The Last Decade

Daniel G. Calame

24 papers receiving 393 citations

Peers

Daniel G. Calame

IMMUN

PRM

SURGE

GENET

Giada Del Baldo Italy

Woosook Kim United States

Klas Strååt Sweden

Imke Meyer Germany

Vassilis Samaras Greece

Kangni Wu China

Katja Simon‐Keller Germany

Melissa Thal United States

M. Anna Kowalska United States

Elya A. Shamskhou United States

Giada Del Baldo Italy

Daniel G. Calame

144 ×1.1

34 ×0.3

IMMUN

77 ×0.8

PRM

90 ×1.0

SURGE

115 ×1.4

GENET

Citations per year, relative to Daniel G. Calame Daniel G. Calame (= 1×) peers Giada Del Baldo

Countries citing papers authored by Daniel G. Calame

Since Specialization

Citations

This map shows the geographic impact of Daniel G. Calame's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel G. Calame with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel G. Calame more than expected).

Fields of papers citing papers by Daniel G. Calame

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel G. Calame. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel G. Calame. The network helps show where Daniel G. Calame may publish in the future.

Co-authorship network of co-authors of Daniel G. Calame

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel G. Calame. A scholar is included among the top collaborators of Daniel G. Calame based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel G. Calame. Daniel G. Calame is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Du, Haowei, Lauren Westerfield, Yelin Wu, et al.. (2025). Expanding the Clinical and Molecular Spectrum of TUBB2B Through Distinct Variants Identified Across Multiple Families. medRxiv.

Chong, Jessica X., Seth Berger, Samantha Baxter, et al.. (2024). Considerations for reporting variants in novel candidate genes identified during clinical genomic testing. Genetics in Medicine. 26(10). 101199–101199. 3 indexed citations

Calame, Daniel G., et al.. (2024). ATP1A3 Disease Spectrum Includes Paroxysmal Weakness and Encephalopathy Not Triggered by Fever. Neurology Genetics. 10(3). e200150–e200150.

Calame, Daniel G. & Lisa Emrick. (2024). Functional genomics and small molecules in mitochondrial neurodevelopmental disorders. Neurotherapeutics. 21(1). e00316–e00316. 1 indexed citations

Park, Young Nyun, et al.. (2024). Protein family FAM241 in human and mouse. Mammalian Genome. 36(1). 83–92.

Marafi, Dana, Ruizhi Duan, Jawid M. Fatih, et al.. (2024). Genomic Balancing Act: deciphering DNA rearrangements in the complex chromosomal aberration involving 5p15.2, 2q31.1, and 18q21.32. European Journal of Human Genetics. 33(2). 231–238. 4 indexed citations

Calame, Daniel G. & Kristen Fisher. (2024). Improving Prognostication in Hypoxic-Ischemic Encephalopathy. JAMA Network Open. 7(12). e2449197–e2449197. 1 indexed citations

Marafi, Dana, Ruizhi Duan, Shalini N. Jhangiani, et al.. (2023). Novel LSS variants in alopecia and intellectual disability syndrome: New case report and clinical spectrum of LSS ‐related rare disease traits. Clinical Genetics. 104(3). 344–349.

Du, Haowei, Angad Jolly, Christopher M. Grochowski, et al.. (2023). HMZDupFinder: a robust computational approach for detecting intragenic homozygous duplications from exome sequencing data. Nucleic Acids Research. 52(4). e18–e18. 2 indexed citations

10.

Calame, Daniel G., Tadahiro Mitani, Jawid M. Fatih, et al.. (2022). Novel RETREG1 (FAM134B) founder allele is linked to HSAN2B and renal disease in a Turkish family. American Journal of Medical Genetics Part A. 188(7). 2153–2161. 3 indexed citations

11.

Calame, Daniel G., et al.. (2021). A novel ATP1A2 variant associated with severe stepwise regression, hemiplegia, epilepsy and movement disorders in two unrelated patients. European Journal of Paediatric Neurology. 31. 21–26. 5 indexed citations

12.

Calame, Daniel G., Jawid M. Fatih, Isabella Herman, et al.. (2021). Deep clinicopathological phenotyping identifies a previously unrecognized pathogenic EMD splice variant. Annals of Clinical and Translational Neurology. 8(10). 2052–2058.

13.

Herman, Isabella, Angad Jolly, Haowei Du, et al.. (2021). Quantitative dissection of multilocus pathogenic variation in an Egyptian infant with severe neurodevelopmental disorder resulting from multiple molecular diagnoses. American Journal of Medical Genetics Part A. 188(3). 735–750. 7 indexed citations

14.

Calame, Daniel G., Isabella Herman, Jawid M. Fatih, et al.. (2021). Risk of sudden cardiac death in EXOSC5‐related disease. American Journal of Medical Genetics Part A. 185(8). 2532–2540. 10 indexed citations

15.

Calame, Daniel G., Jawid M. Fatih, Isabella Herman, et al.. (2021). Biallelic Pathogenic Variants in TNNT3 Associated With Congenital Myopathy. Neurology Genetics. 7(3). e589–e589. 9 indexed citations

16.

Calame, Daniel G., Isabella Herman, & James J. Riviello. (2021). A de novo heterozygous rare variant in SV2A causes epilepsy and levetiracetam-induced drug-resistant status epilepticus. Epilepsy & Behavior Reports. 15. 100425–100425. 13 indexed citations

17.

Calame, Daniel G., et al.. (2020). Degos disease: A radiological-pathological correlation of the neuroradiological aspects of the disease. Annals of Diagnostic Pathology. 47. 151545–151545. 4 indexed citations

18.

Dong, Xiaomin, Natalie B. Tan, Katherine B. Howell, et al.. (2020). Bi-allelic LoF NRROS Variants Impairing Active TGF-β1 Delivery Cause a Severe Infantile-Onset Neurodegenerative Condition with Intracranial Calcification. The American Journal of Human Genetics. 106(4). 559–569. 18 indexed citations

19.

Calame, Daniel G., Stacey L. Mueller‐Ortiz, & Rick A. Wetsel. (2016). Innate and adaptive immunologic functions of complement in the host response to Listeria monocytogenes infection. Immunobiology. 221(12). 1407–1417. 23 indexed citations

20.

Wang, Dachun, John E. Morales, Daniel G. Calame, Joseph L. Alcorn, & Rick A. Wetsel. (2010). Transplantation of Human Embryonic Stem Cell–Derived Alveolar Epithelial Type II Cells Abrogates Acute Lung Injury in Mice. Molecular Therapy. 18(3). 625–634. 108 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact